Among SLE patients, 6.5% had a homozygous deficiency (i.e., 0 copy) of C4A and 26.4% had a heterozygous deficiency (i.e., 1 copy), compared to 1.3 and 18.2%, respectively, in healthy controls. This evidence concerns the gene C4A and systemic lupus erythematosus.